依诺肝素钠治疗非ST段抬高心肌梗死的疗效及护理策略分析被引量：4

Analysis on the Efficacy and Nursing Strategy of the Enoxaparin Sodium for Treating Non-ST-Segment Elevation Myocardial Infarction

下载PDF

导出

摘要目的观察依诺肝素钠治疗非ST段抬高心肌梗死患者的疗效,同时提出相应的护理策略。方法选取47例急性心肌梗死患者,随机分为观察组24例和对照组23例。观察组给予依诺肝素钠注射液治疗,对照组给予普通肝素钠注射液治疗,同时对两组患者给予针对性护理干预。对两组患者的心肌梗死标志物、心血管性事件、血脂参数、血清氧化型低密度脂蛋白(ox-LDL)和高敏C-反应蛋白(hs-CRP)进行检测分析。结果两组患者用药后除高密度脂蛋白胆固醇(HDL-C)外所有指标均显著改善(P<0.05),观察组心肌梗死标志物、出血及心绞痛事件、血脂参数、ox-LDL及hs-CRP的改善程度显著优于对照组(P<0.05)。结论依诺肝素钠治疗非ST段抬高心肌梗死效果好且不良反应发生率低,实施针对性护理干预有助于患者的恢复,值得临床推广。 Objective To investigate and analyze the effect of enoxaparin sodium for treating the patients with non-ST-segment elevation myocardial infarction,and to propose the corresponding nursing strategy. Methods 47 patients with acute myocardial infarction treated in our hospital were selected as the study subjects and randomly divided into the observation group（ 24 cases） and the control group（ 23cases）. The observation group was given the enoxaparin sodium injection treatment,while the control group was given the common heparin sodium therapy. At the same time the two groups were performed the targeted nursing intervention; the myocardial infarction markers,cardiovascular events,lipid parameters,serum oxidized low-density lipoprotein and high sensitive C-reactive protein（ hs-CRP） were detected for conducting the statistical analysis. Results All indicators except HDL-C after medication in the two groups were significantly improved（ P〈0. 05）; the improvement degrees of the myocardial infarction markers,bleeding,angina events,lipid parameters,ox-LDL and hs-CRP in the observation group were significantly better than those in the control group（ P〈0. 05）. Conclusion Enoxaparin sodium has better effect and low occurrence rate of adverse reactions for treating non-ST-segment elevation myocardial infarction; implementing the targeted nursing intervention is conducive to the patient＇s recovery and worthy of clinical promotion.

作者王云湛又菁

机构地区中国人民解放军第三军医大学第二附属医院

出处《中国药业》 CAS 2015年第1期93-95,共3页 China Pharmaceuticals

关键词依诺肝素钠非ST段抬高心肌梗死护理 enoxaparin sodium non-ST-segment elevation myocardial infarction nursing care

分类号 R969.4 [医药卫生—药理学] R973.2 [医药卫生—药品]

引文网络
相关文献

参考文献11

1Bagai A, White JA, Lokhnygina Y, et al. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high - risk non - ST - segment elevation acute coronary syndromes patients: an analy- sis from the Early Glycoprotei Ilb/IIIa Inhibition in Non -ST- Segment Elevation Acute Coronary Syndrome trial [ J ]. Am Heart J, 2013,166 (3) : 466 - 473.
2Montalescot G, Bolognese L, Dudek D, et at. Pretreatment with prasugrel in non - ST - segment elevation acute coronary syndromes [ J]. N Engl J Med, 2013,369(11): 999 - 1 010.
3林善红.静脉溶栓治疗急性心肌梗死50例[J].中国药业,2013,22(1):87-88. 被引量：4
4龙桂均,黄群英,张伟.急性心肌梗死患者经皮冠状动脉介入治疗术中并发症对近期心功能的影响[J].广东医学,2013,34(19):2953-2956. 被引量：4
5Acharjee S, Roe MT, Amsterdam EA, et al. Relation of admission high - density lipoprotein cholesterol level and in - hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry) [ J ]. Am J Cardiol, 2013,112 (8) : 1 057 - 1 062.
6Klutstein MW, Westerhout CM, Armstrong PW, et al. Radial versus femoral access,bleeding and ischemic events in patients with non -ST- segmentelevation acute coronary syndrome managed with an invasivestrategy[J]. Am Heart J,2013,165(4): 583 - 590.
7蒋桦,夏春,周学继,王心捷.辛伐他汀对急性心肌梗死的疗效及血脂水平的影响[J].中国药业,2013,22(12):59-61. 被引量：1
8李昭,陶英,黄觊,王茜,张冬花,吴翔宇.青年男性心肌梗死的高密度脂蛋白胆固醇特点及其与冠状动脉病变的关系[J].中华高血压杂志,2013,21(10):1000-1000. 被引量：2
9Collet JP, Huber K, Cohen M, et al. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)[J]. Am J Cardiol,2013,112(9): 1 367 - 1 372.
10Zahir H, Matsushima N, Halim AB, et al. Edoxaban administration follow- ing enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects[J] .Thromb Haemost, 2012, 108(1): 166 - 175.

二级参考文献26

1Collaborative Research Group of National“Eighth Five year”Project(85 915 02 01) (Fu Wai Hospital,CAMS and PUMC,Beijing 100037).急性心肌梗死尿激酶溶栓治疗开始时间对疗效的影响[J].中国循环杂志,1996,11(7):387-389. 被引量：47
2急性心肌梗塞溶栓疗法参考方案（1996年7月修订）[J].中华心血管病杂志,1996,24(5):328-329. 被引量：1321
3刘桂蕊张恩清孙美等.急性心肌梗死再灌注心律失常.临床荟萃,2003,15(1):45-45.
4Stone GW, Grines CL, Oneil WW. Primary corona angioplasty versus thrombolysis[J]. N Eng J Med, 1997,337(16) : 1 168 - 1 169.
5A1- Mallah MH, Hatahet H, Cavalcante JL, et al. Low admission LDL- cholesterol is associated with increased 3 - year all - cause mortality in pa- tients with non ST segment elevation myocardial infarction[J]. Cardiol J, 2009, 16 (3) : 227 - 233.
6BEITNES J 0,GJESDAL 0,LUNDE K, et al. Left ventricularsystolic and diastolic function improve after acute myocardial in-farction treated with acute percutaneous coronary intery - vention,but are not influenced by intracoronary injection of autologousmononuclear bone marrowcells: a 3 year serial echocardiographicsub - study of the randomized - controlled ASTAMI study [ J ]. EurJ Echocardiogr, 2011, 12(2) : 98 - 106.
7YIPHK, HANG C L,FANG C Y,et al. Lvel of high - sensitivi-ty Ctiveprote in 15 predietive of 30 - day outcomes in patiens withacute myocardial in farction undergoing primary coronary interven-tion[J]. Chest, 2005, 127(3) : 803 -808.
8REFFELMANN T,KLONER R A. The " no - reflow" phenome-non :basic science and clinical correlates [ J]. Heart,2002,87(2) : 162 -168.
9FURBER A P, PRUNIER F, NGUYEN H C,et al. Coronaryblood flow assessment after successful angioplasty for acute myocar-dial infarction predicts the risk of long - term cardiac events [ J ].Circulation, 2004, 110(23) : 3527 -3533.
10NAKAMURA T, AKO J, KADOWAKI T, et al. Impact of acutehyperglyce - mia during primary stent implantation in patients withST - elevation myo - cardial infarction[ J]. J Cardiol, 2009, 53(2) : 272 -277.